Risk of venous thromboembolic disease in postmenopausal women taking oral or transdermal hormone replacement therapy.
about
Assessment of ghrelin and leptin receptor levels in postmenopausal women who received oral or transdermal menopausal hormonal therapyHormones, herbal preparations and nutriceuticals for a better life after the menopause: part I.Adiponectin and endothelial markers in postmenopausal women taking oral or transdermal hormone therapy.
P2860
Risk of venous thromboembolic disease in postmenopausal women taking oral or transdermal hormone replacement therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Risk of venous thromboembolic ...... l hormone replacement therapy.
@ast
Risk of venous thromboembolic ...... l hormone replacement therapy.
@en
Risk of venous thromboembolic ...... l hormone replacement therapy.
@nl
type
label
Risk of venous thromboembolic ...... l hormone replacement therapy.
@ast
Risk of venous thromboembolic ...... l hormone replacement therapy.
@en
Risk of venous thromboembolic ...... l hormone replacement therapy.
@nl
prefLabel
Risk of venous thromboembolic ...... l hormone replacement therapy.
@ast
Risk of venous thromboembolic ...... l hormone replacement therapy.
@en
Risk of venous thromboembolic ...... l hormone replacement therapy.
@nl
P2093
P2860
P356
P1476
Risk of venous thromboembolic ...... l hormone replacement therapy.
@en
P2093
Barbara Góralczyk
Barbara Ruszkowska
Danuta Rość
Grażyna Gadomska
Liliana Bielis
Marzena Gruszka
P2860
P2888
P356
10.1631/JZUS.B1000106
P577
2011-01-01T00:00:00Z
P6179
1017652879